Savara (SVRA) announced that the results from the Phase 3 IMPALA-2 clinical trial will be published online in NEJM. The manuscript will appear in the online version of the publication. Following the online publication in NEJM, the manuscript will be available on the Congresses & Publications page of the company’s corporate website.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SVRA: